stroke
Conditions
Interventions
experimental group:BCI therapy
Sponsors
Huashan Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. The onset time was 2 weeks to 1 year and the disease was stable; 2. Patients with first and unilateral cerebral infarction confirmed by cranial computed tomography (CT) or magnetic resonance imaging (MRI) (diagnosis is in line with the consensus of "Key Diagnostics of Various Major Cerebrovascular Diseases in China 2019" formulated by Cerebrovascular Group of Neurology Society of Chinese Medical Association); 3. Age 18 to 75 years old (including 18 and 75 years old); 4. The Fugl-Meyer Assessment Upper Limb scale (FMA-UL) score is = 22; 7. Those who signed the informed consent after being selected.
Exclusion criteria
Exclusion criteria: 1. Patients receiving other non-invasive brain Stimulation interventions, such as Transcranial Magnetic Stimulation (TMS) or Transcranial direct-current Stimulation (TDCS); 2. Poor compliance; 3. With other serious medical diseases (such as heart failure, respiratory failure, renal insufficiency, uncontrollable hypertension, arrhythmia, severe coronary heart disease, diabetes complications poorly controlled); 4. With any acute or chronic infection (such as tuberculosis, intracranial infection, etc.); 5. Pregnancy; 6. Participants in other clinical trials at the same time; 7. Those with junior high school education level or below.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl-Meyer assessment scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Action Research Arm Test;EEG;modified Barthel index;NIHSS;rs-fMRI;DTI; | — |
Countries
China
Contacts
Public ContactJia Jie
Huashan Hospital, Fudan University
Outcome results
None listed